EFFECTS OF 1,25-DIHYDROXYVITAMIN-D(3) ON PROLIFERATION AND DIFFERENTIATION OF CACO-2 CELLS

被引:80
|
作者
HALLINE, AG
DAVIDSON, NO
SKAROSI, SF
SITRIN, MD
TIETZE, C
ALPERS, DH
BRASITUS, TA
机构
[1] WASHINGTON UNIV, SCH MED, DEPT GASTROENTEROL, ST LOUIS, MO 63110 USA
[2] UNIV CHICAGO, DEPT GASTROENTEROL, CHICAGO, IL 60637 USA
关键词
D O I
10.1210/en.134.4.1710
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3], or calcitriol, on the proliferation and differentiation of Caco-2 cells was studied. Vitamin D receptor mRNA was detected in both pre- and postconfluent cells, and its abundance was unchanged with time and in response to calcitriol. 1,25-(OH)2D3-binding activity increased during differentiation, but there was no difference in binding between 1,25-(OH)2D3-treated and control cells. 1,25-(OH)2D3 caused a dose-dependent reduction in proliferation, as assessed by [H-3]thymidine incorporation and DNA content. 1,25-(OH)2D3 significantly enhanced the normal rise in alkaline phosphatase activity during differentiation and increased alkaline phosphatase mRNA abundance. In contrast, 1,25-(OH)2D3 inhibited the normal rise in sucrase-isomaltase activity and the corresponding mRNA level, although the inhibition occurred after the initial period of cell differentiation (>10 days postplating). Morphological analysis demonstrated that by day 12 postplating, 1,25-(OH)2D3 increased the mean dome diameter and microvillus length and density. Although 1,25-(OH)2D3 decreases the proliferation of Caco-2 cells and enhances certain parameters of differentiation, not all brush-border hydrolases respond in a similar fashion, making it necessary to interpret with caution their individual use as markers of differentiation.
引用
收藏
页码:1710 / 1717
页数:8
相关论文
共 50 条
  • [31] 1,25-DIHYDROXYVITAMIN-D RESISTANCE, RICKETS, AND ALOPECIA
    HOCHBERG, Z
    BENDERLI, A
    LEVY, J
    VARDI, P
    WEISMAN, Y
    CHEN, T
    FELDMAN, D
    AMERICAN JOURNAL OF MEDICINE, 1984, 77 (05): : 805 - 811
  • [32] RADIOIMMUNOASSAY FOR 1,25-DIHYDROXYVITAMIN-D IN SERUM OR PLASMA
    DELEENHEER, AP
    BAUWENS, RM
    CLINICAL CHEMISTRY, 1985, 31 (01) : 142 - 146
  • [33] ABNORMAL 1,25-DIHYDROXYVITAMIN-D METABOLISM IN PREECLAMPSIA
    AUGUST, P
    MARCACCIO, B
    GERTNER, JM
    DRUZIN, ML
    RESNICK, LM
    LARAGH, JH
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (04) : 1295 - 1299
  • [34] KETOCONAZOLE - A 1,25-DIHYDROXYVITAMIN-D RECEPTOR ANTAGONIST
    HODGE, JW
    EIL, C
    DEGRANGE, DA
    LIBERMAN, UA
    MARX, SJ
    DUNN, JF
    CALCIFIED TISSUE INTERNATIONAL, 1984, 36 (04) : 516 - 516
  • [36] 1,25-DIHYDROXYVITAMIN-D IN SEVERE IMMUNE CHALLENGES
    STACK, KM
    PALMIERI, GMA
    IMMUNOLOGY LETTERS, 1989, 23 (01) : 77 - 77
  • [37] THE PRODUCTION OF 1,25-DIHYDROXYVITAMIN-D IN PRIMARY HYPERPARATHYROIDISM
    THAKKER, RV
    FRAHER, LJ
    SUDAN, HL
    ADAMI, S
    ORIORDAN, JLH
    BONE, 1986, 7 (02) : 153 - 154
  • [38] LACK OF EFFECTS OF 1,25-DIHYDROXYVITAMIN-D AND 24,25-DIHYDROXYVITAMIN-D ON PARATHYROID-HORMONE RESPONSE TO HYPOCALCEMIA IN CATTLE
    VOUMARD, B
    TRECHSEL, U
    FISCHER, JA
    BLUM, JW
    METABOLIC BONE DISEASE & RELATED RESEARCH, 1984, 5 (04): : 171 - 175
  • [39] BONE TURNOVER IN RATS TREATED WITH 1,25-DIHYDROXYVITAMIN-D(3), 25-HYDROXYVITAMIN-D(3) OR 24,25-DIHYDROXYVITAMIN-D(3)
    MORTENSEN, BM
    GAUTVIK, KM
    GORDELADZE, JO
    BIOSCIENCE REPORTS, 1993, 13 (01) : 27 - 39
  • [40] COMPARISONS BETWEEN 2 RECEPTOR ASSAYS FOR 1,25-DIHYDROXYVITAMIN-D
    HARTWELL, D
    CHRISTIANSEN, C
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1988, 48 (02): : 109 - 114